Xenon Pharmaceuticals Inc
(NAS:XENE)
$
43.33
1.62 (3.88%)
Market Cap: 3.28 Bil
Enterprise Value: 2.45 Bil
PE Ratio: 0
PB Ratio: 3.88
GF Score: 41/100 
Xenon Pharmaceuticals Inc at Stifel CNS Days (Virtual) Transcript
Mar 28, 2023 / 05:00PM GMT
Release Date Price:
$34.62
(+0.52%)
Paul Matteis
Stifel Financial Corp. - Analyst
Great. Good afternoon, everybody. It's my pleasure to be with Ian Mortimer, President and CEO of Xenon. Ian, it's always great to see you. We've done a number of panels together even in the past six months, so sorry to have to deal with me again. And Sherry Aulin, CFO. Sorry, Sherry, you disappeared for a second off of my screen, so I didn't know if [you're in this meeting] or not.
Before we start, Ian, did you run this morning? And if so, how far?
Ian Mortimer
Xenon Pharmaceuticals, Inc. - President and CEO
I did run this morning. I did 10 miles, yeah.
Paul Matteis
Stifel Financial Corp. - Analyst
Okay. Easy day?
Ian Mortimer
Xenon Pharmaceuticals, Inc. - President and CEO
Easy day.
Questions & Answers
Paul Matteis
Stifel Financial Corp. - Analyst
All right. That's awesome. Cool, okay. With that, do you want to just give us an update of the 1101 pivotal
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers